Critical care and the urologic patient

Critical Care Clinics

Volumn 19, Issue 1, 2003, Pages 1-10

  Leung, Anne K H ^a   Tan, Ian K S ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN;

ADRENALECTOMY; ANALGESIA; BLADDER RECONSTRUCTION; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; HEALTH CARE COST; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY ARTERY STENOSIS; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MORTALITY; NEPHRECTOMY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; SEPSIS; SYNDROME; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION SYNDROME; TREATMENT INDICATION; URINARY TRACT DISEASE;

ANGIOPLASTY, BALLOON; CRITICAL CARE; CYSTECTOMY; HUMANS; MALE; RENAL ARTERY OBSTRUCTION; TRANSURETHRAL RESECTION OF PROSTATE; UROLOGIC DISEASES; UROLOGIC SURGICAL PROCEDURES; VENOUS THROMBOSIS;

EID: 0037233173     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00049-0     Document Type: Review

References (53)

1. Gill IS, Clayman RV, McDougall EM. Advances in urological laparoscopy. J Urol 1995; 154(4):1275-94.
2. Hedican SP. Laparoscopy in urology. Surg Clin North Am 2000;80(5):1465-85.
3. Menon M. Urology. J Am Coll Surg 2000;190(2):244-52.
4. Fahlenkamp D, Rassweiler J, Fomara P, et al. Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. J Urol 1999;162(3 Pt 1): 765-70.
5. Guillonneau B, Rozet F, Cathelineau X, et al. Perioperative complications of laparocopic radical prostatectomy: the Montsouris 3-year experience. J Urol 2002;167(1):51-6.
6. Clarke PB. Radical cystectomy for carcinoma of the bladder. Br J Urol 1978;50(7):492-5.
7. Figueroa AJ, Stein JP, Dickinson M, et al. Radical cystectomy for elderly patients with bladder carcinoma: an update experience with 404 patients. Cancer 1998;83(1):141-7.
8. Rosario DJ, Becker M, Anderson JB. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int 2000;85(4):427-30.
9. Game X, Soulie M, Seguin P, et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol 2001;39(5):525-9.
10. Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol 1999; 161(4):1057-66.
11. Hautmann RE, Miller K, Steiner U, et al. The ileal neobladder: 6 years of experience with more than 200 patients. J Urol 1993;150(1):40-5.
12. Frazier HA, Robertson JE, Paulson DF. Complication of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. J Urol 1992;148(5):1401-5.
13. N'Dow J, Neal DE. Female adult reconstructive urology. Br J Urol 1997;80(Suppl 1):69-78.
14. Wheeler HB. Diagnosis of deep vein thrombosis. Review of clinical evaluaton and impedence plethysmography. Am J Surg 1985;150(4A):7-13.
15. Kibel AS, Loughlin KR. Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery. J Urol 1995;153(6):1763-74.
16. Hansberry KL, Thompson Jr. IM, Bauman J, et al. A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery. J Urol 1991;145(6):1205-8.
17. Van Arsdalen KN, Bames RW, Clarke G, et al. Deep vein thrombosis and prostectomy. Urology 1983;21(5):461-3.
18. Bigg SW, Catalona WJ. Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology 1992;39(4):309-13.
19. Holbraad L, Thybo E, Vennits H. A controlled investigation of the value of anticoagulant therapy in cases of prostatectomy. Scand J Urol Nephrol 1976;10(1):39-42.
20. Chandhoke PS, Gooding GA, Narayan P. Prospective randomized trial of warfarin and intermittent pneumatic leg compression as prophylaxis for postoperative deep venous thrombosis in major urological surgery. J Urol 1992;147(4):1056-9.
21. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346(13):975-80.
22. Hendry WF. Morbidity and mortality of radical cystectomy (1971-78 and 1978-85). J R Soc Med 1986;79(7):395-400.
23. Dahm P, Tuttle-Newhall JE, Yowell CW, et al. Indications for surgical intensive care unit admission of postoperative urologic patients. Urology 2000;55(3):334-8.
24. Chang SS, Alberts G, Cookson MS, et al. Radical cystectomy is safe in elderly patients at high risk. J Urol 2001;166(3):938-41.
25. Mebust WK. Transurethral surgery. In: Walsh PC, Retik AB, editors. Campbell's urology. 7th ed. Philadelphia: W.B. Saunders; 1998. p. 1511-28.
26. Gilling PJ, Mackey M, Cresswell M, et al. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow up. J Urol 1999;162(5):1640-4.
27. Floratos DL, de La Rosette JM. Heat treatment of the prostate: where do we stand in 2000? Curr Opin Urol 2001;11(1):35-41.
28. Mebust WK, Holtgrewe HL, Cockett ATK, et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluation 3,885 patients. J Urol 1989;141(2):243-7.
29. Borboroglu PG, Kane CJ, Ward JF, et al. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999;162(4):1307-10.
30. Brehmer B, Madsen PO. Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J Urol 1972;108(5):719-21.
31. McEntee GP, McPhail S, Mulvin D, et al. Single dose antibiotic prophylaxis in high risk patients undergoing transurethral prostatectomy. Br J Surg 1987;74(3):192-4.
32. Naber KG, Bergman B, Bishop MC, et al. Urinary tract infection (UTI) EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001;40(5):576-88.
33. Berry A, Barratt A. Prophylatic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol 2002;167(2 Pt 1):571-7.
34. Childs SJ. Appropriate surgical prophylaxis in transurethral genitourinary surgery and potential reduction in nosocomial infections. Urology 1986;27(5):415-20.
35. Paradisi F, Corti G, Mangani V. Urosepsis in the critical care unit. Crit Care Clin 1998; 14(2):165-80.
36. Agarwal R, Emmett M. The post-transurethral resection of prostate syndrome: therapeutic proposals. Am J Kidney Dis 1994;24(1):108-11.
37. Dixon B, Ernest D. Hyponatraemia in the transurethral resection of prostate syndrome. Anaesth Intensive Care 1996;24(1):102-3.
38. Vaughan Jr ED, Sosa RE. Renovascular hypertension and other renal vascular diseases. In: Walsh PC, Retik AB, editors. Campbell's urology. 7th ed. Philadelphia: W.B. Saunders; 1998. p. 423-59.
39. Novick AC. Atherosclerotic ischemic nephropathy: epidemiology and clinical considerations. Urol Clin North Am 1994;21(2):195-200.
40. Safian RD, Textor SC. Renal artery stenosis. N Engl J Med 2001;344(6):431-42.
41. Cambria RP, Brewster DC, L'Italien GJ, et al. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg 1994;20(1):76-85.
42. Hallett Jr JW, Fowl R, O'Brien PC, et al. Renovascular operations in patients with chronic renal insufficiency: do the benefits justify the risks? J Vasc Surg 1987;5(4):622-7.
43. Lawrie GM, Morris Jr GC, Glaeser DH, et al. Renovascular reconstruction: factors affecting long-term prognosis in 919 patients followed up to 31 years. Am J Cardiol 1989;63(15):1085-92.
44. Diehl JT, Cali RF, Hertzer NR, et al. Complications of abdominal aortic reconstruction. An analysis of perioperative risk factors in 557 patients. Ann Surg 1983;197(1):49-56.
45. Sorcini A, Libertino JA. Vascular reconstruction in urology. Urol Clin North Am 1999;26(1): 219-34.
46. van Jaarsveld BC, Deinum J. Evaluation and treatment of renal artery stenosis: impact on blood pressure and renal function. Curr Opin Nephrol Hypertens 2001;10(3):399-404.
47. Kidney DD, Deutsch LS. The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis. Semin Vasc Surg 1996;9(3):188-97.
48. Dorros G, Jaff MR, Mathiak L. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98(7):642-7.
49. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of ballon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative. N Engl J Med 2000;342(14):1007-14.
50. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and ballon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet 1999;353:282-6.
51. Paulsen D, Klow NE, Rogstad B, et al. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol Dial Transplant 1999;14(6):1454-61.
52. Plouin PF, Chatellier G, Dame B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31(3):823-9.
53. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12(5):329- 35.